Godawari Power & Ispat Operations Commence at Enhanced Capacity for Ari Dongri Iron Ore Mines
Godawari Power & Ispat Limited (GPIL) has announced the commencement of mining operations at its Ari Dongri Iron Ore Mines following the…
Balu Forge Industries ICRA Upgrades Credit Ratings for Bank Facilities
Balu Forge Industries announced that ICRA Limited has upgraded the credit ratings for the company’s bank borrowing facilities. Key…
Nuvama Wealth Management Keynote Presentation Highlights on India’s Wealth Ecosystem Evolution
Nuvama Wealth Management presented its ‘Industry & Strategic Overview’ by Mr. Ashish Kehair, MD and CEO, at the Nuvama India…
JSW Steel Reports Consolidated Crude Steel Production of 24.75 Lakh Tonnes for January 2026
JSW Steel announced its consolidated Crude Steel production for January 2026 reached 24.75 Lakh Tonnes, marking a 2% year-over-year (YoY)…
ACME Solar Holdings Limited Awarded LOA for 220 MW Solar + BESS Project by RUMSL
ACME Solar Holdings Limited has received a Letter of Award (LOA) from Rewa Ultra Mega Solar Limited (RUMSL) to establish a 220 MW Solar with…
Ceigall India Limited Expands Renewable Portfolio with ₹1,700 Crore Solar and BESS Award in Madhya Pradesh
Ceigall India Limited announced on February 10, 2026, that it has secured a significant Letter of Award (LOA) worth approximately ₹1,700 crore…
NMDC Limited Announcement of New Iron Ore Prices Effective February 10, 2026
NMDC Limited has announced the revised prices for Baila Lump and Baila Fines grades of Iron Ore, effective from February 10, 2026. Baila Lump…
Cipla Subsidiary InvaGen Receives Two Observations Post-USFDA Inspection
Cipla Limited has disclosed that its wholly owned subsidiary, InvaGen Pharmaceuticals, located in Hauppauge, New York, underwent a…
Lupin Limited Settlement Reached in Mirabegron Patent Infringement Dispute with Astellas
Lupin has announced the resolution of its patent infringement dispute concerning its product ‘Mirabegron’ against Astellas Pharma…
Aurobindo Pharma Reports 8.4% YoY Revenue Growth in Q3FY26 Earnings
Aurobindo Pharma announced its Unaudited Financial Results for Q3FY26, showcasing robust top-line growth. Revenue from operations reached…